Joincare Pharmaceutical to Divest 49% Stake in Animal Health Unit For 51.5 Million Yuan

MT Newswires Live

Dec 31, 2025

Joincare Pharmaceutical Group Industry (SHA:600380) plans to divest its entire 49% stake in its animal health subsidiary for 51.5 million yuan to focus on its core business areas.

The Chinese pharmaceutical company will sell the stake in Maohaizi Animal Health (Guangdong) to its related party, Shenzhen Xinyou Maohai Investment Partnership (Limited Partnership).

Post-transaction, Xinyou Maohai will hold 52.6% of Maohaizi's equity, while Joincare's controlling shareholder, Livzon Pharmaceutical Group Co., the parent company of Livzon Pharmaceutical Group Inc. (HKG:1513, SHE:000513), will hold the remaining 47.4% stake.

Joincare Pharmaceutical will no longer directly hold any stake in the animal health company following the transaction.

The company cited the "weak synergy" between Maohaizi's main business and the company's strategy as the reason for the divestment.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2595749652"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2595749652\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2595749652?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-31 09:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2595749652","market":"us","top_or_hot":-1,"title":"Joincare Pharmaceutical to Divest 49% Stake in Animal Health Unit For 51.5 Million Yuan","media":"MT Newswires Live","content":"<html><body><p> Joincare Pharmaceutical Group Industry (SHA:600380) plans to divest its entire 49% stake in its animal health subsidiary for 51.5 million yuan to focus on its core business areas.</p><p>The Chinese pharmaceutical company will sell the stake in Maohaizi Animal Health (Guangdong) to its related party, Shenzhen Xinyou Maohai Investment Partnership (Limited Partnership).</p><p>Post-transaction, Xinyou Maohai will hold 52.6% of Maohaizi's equity, while Joincare's controlling shareholder, Livzon Pharmaceutical Group Co., the parent company of <a href=\"https://laohu8.com/S/LVZPF\">Livzon Pharmaceutical Group Inc.</a> (HKG:1513, SHE:000513), will hold the remaining 47.4% stake.</p><p>Joincare Pharmaceutical will no longer directly hold any stake in the animal health company following the transaction.</p><p>The company cited the \"weak synergy\" between Maohaizi's main business and the company's strategy as the reason for the divestment.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Joincare Pharmaceutical to Divest 49% Stake in Animal Health Unit For 51.5 Million Yuan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJoincare Pharmaceutical to Divest 49% Stake in Animal Health Unit For 51.5 Million Yuan\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-12-31 09:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Joincare Pharmaceutical Group Industry (SHA:600380) plans to divest its entire 49% stake in its animal health subsidiary for 51.5 million yuan to focus on its core business areas.</p><p>The Chinese pharmaceutical company will sell the stake in Maohaizi Animal Health (Guangdong) to its related party, Shenzhen Xinyou Maohai Investment Partnership (Limited Partnership).</p><p>Post-transaction, Xinyou Maohai will hold 52.6% of Maohaizi's equity, while Joincare's controlling shareholder, Livzon Pharmaceutical Group Co., the parent company of <a href=\"https://laohu8.com/S/LVZPF\">Livzon Pharmaceutical Group Inc.</a> (HKG:1513, SHE:000513), will hold the remaining 47.4% stake.</p><p>Joincare Pharmaceutical will no longer directly hold any stake in the animal health company following the transaction.</p><p>The company cited the \"weak synergy\" between Maohaizi's main business and the company's strategy as the reason for the divestment.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"000513","symbol_name":"丽珠集团","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2595749652","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2595749652","pubTimestamp":1767142893,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Joincare Pharmaceutical Group Industry  plans to divest its entire 49% stake in its animal health subsidiary for 51.5 million yuan to focus on its core business areas.The Chinese pharmaceutical company will sell the stake in Maohaizi Animal Health  to its related party, Shenzhen Xinyou Maohai Investment Partnership .Post-transaction, Xinyou Maohai will hold 52.6% of Maohaizi's equity, while Joincare's controlling shareholder, Livzon Pharmaceutical Group Co., the parent company of Livzon Pharmaceutical Group Inc. , will hold the remaining 47.4% stake.Joincare Pharmaceutical will no longer directly hold any stake in the animal health company following the transaction.The company cited the \"weak synergy\" between Maohaizi's main business and the company's strategy as the reason for the divestment.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"600380":"健康元","000513":"丽珠集团","BK0188":"融资融券","BK1191":"制药","BK0114":"健康中国","BK0077":"质押式回购","BK0046":"生物疫苗","BK0187":"一线龙头","01513":"丽珠医药","BK0028":"国家队","BK0239":"医药制造"},"translate_title":"健康元药业将以5150万元剥离动物保健部门49%股权","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600380":0.9,"000513":0.9,"01513":0.9},"content_text":"Joincare Pharmaceutical Group Industry (SHA:600380) plans to divest its entire 49% stake in its animal health subsidiary for 51.5 million yuan to focus on its core business areas.The Chinese pharmaceutical company will sell the stake in Maohaizi Animal Health (Guangdong) to its related party, Shenzhen Xinyou Maohai Investment Partnership (Limited Partnership).Post-transaction, Xinyou Maohai will hold 52.6% of Maohaizi's equity, while Joincare's controlling shareholder, Livzon Pharmaceutical Group Co., the parent company of Livzon Pharmaceutical Group Inc. (HKG:1513, SHE:000513), will hold the remaining 47.4% stake.Joincare Pharmaceutical will no longer directly hold any stake in the animal health company following the transaction.The company cited the \"weak synergy\" between Maohaizi's main business and the company's strategy as the reason for the divestment.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}